Norfloxacin
Back to searchMolecule Structure
Scientific Name
Norfloxacin
Description of the Drug
Norfloxacin is a broad-spectrum fluoroquinolone antibiotic with variable activity against gram-positive and gram-negative bacteria. Typically reserved for the treatment of UTIs due to accumulation in the urine.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01059
http://www.drugbank.ca/drugs/DB01059
Brand Name(s)
Baccidal, Chibroxin, Noroxin, Quinabic, Utinor
Company Owner(s)
Merck Research Laboratories Div Merck Co Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311224 |
Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363076 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL3473 | ||
PharmGKB | PA450654 | ||
Human Metabolome Database | HMDB0015192 | ||
DrugBank | DB01059 | ||
PubChem: Thomson Pharma | 14874649 | ||
PubChem | 4539 | 6919051 | |
Mcule | MCULE-1115657359 | ||
LINCS | LSM-5286 | ||
Nikkaji | J1.144D | ||
BindingDB | 50045000 | ||
EPA CompTox Dashboard | DTXSID7037680 | ||
DrugCentral | 1967 | ||
Brenda | 229734 | 229735 | 15890 |
ChemicalBook | CB1711035 | ||
rxnorm | NORFLOXACIN | ||
PubChem: Drugs of the Future | 12013332 | ||
KEGG Ligand | C06687 | ||
ChEBI | 100246 | ||
ZINC | ZINC000000003742 |